Eqqualberry’s Vitamin Illuminating Serum Original illustrates why the largest ingredient percentage is not always the percentage a reader expects. Fruit water, a named vitamin derivative and a separate niacinamide declaration are distinct facts. A melasma comparison should preserve those identities before discussing an appearance claim.
Tone Notes reviewed the official Original-serum page and refund policy on October 14, 2026. The listing was sold out, and no order or product-use test was completed. We describe the specific formula record without borrowing a price, availability claim or study conclusion from another item in the brand’s range.
- Reviewed version
- Original, 30 ml
- Acerola claim
- 40% fruit water; not 40% pure vitamin C
- Other declarations
- 4% niacinamide; 10 ppm vitamin C derivative
- Offer status
- Sold out; current purchasable price unestablished
- Returns
- Unused-item conditions; individual claims reviewed
Forty percent acerola water is not forty percent vitamin C
The product presentation identifies 40% acerola fruit water. It separately declares niacinamide at 4% and 3-O-Ethyl Ascorbic Acid at 10 ppm. The latter amount converts to 0.001%. These declarations should not be combined into a claim that the finished serum contains forty-percent pure vitamin C. [1]
A botanical material may be discussed for its constituents, but its total percentage does not quantify each constituent within it. Our cosmetic comparison guide keeps the exact named ingredients and units beside one another. The conversion explains the label rather than supplying a clinical potency score.
The reviewed formula must remain the Original version
The checked product is the 30 ml Vitamin Illuminating Serum Original. Similar names elsewhere in the store, including bundles, do not establish that their ingredient lists or offers are interchangeable. The exact version should be visible on a future order and package before this review is used as a comparison. [1]
The captured page marked this item sold out, and a current purchasable price was not established. We therefore provide no invented single-bottle cost or cost-per-month estimate. A neighboring promotion would need its own verified product identity, quantity and purchase terms before it could answer that question.
A study reference is not a complete melasma appraisal
The official presentation refers to Intertek work from 2024 and labels imagery as illustrative. We did not independently appraise a full report establishing a defined melasma population, a suitable comparison group and a result for this exact current preparation. The source reference is useful, but its limits should remain visible. [1]
A cosmetic brightening observation also cannot diagnose the reason for discoloration. AAD’s treatment information provides the clinical context for that distinction. The pigment guide explains why a product’s audience description should not be substituted for an assessment of the individual concern. [3]
More named ingredients do not settle routine compatibility
The full routine matters when a reader is considering another serum alongside prescribed or over-the-counter products. Neither the fruit-water percentage nor the niacinamide declaration establishes that adding it will be useful or comfortable in a particular combination. This publication did not test layering, residue, scent or tolerance.
AAD’s self-care advice discusses avoiding irritation as part of melasma care. That is general educational context rather than a product-specific approval. Our maintenance discussion treats consistency and the established plan as questions to consider, without giving an individualized schedule for this serum. [4]
Return eligibility depends on the condition of the item
The policy describes a thirty-day period from receipt for unused items and a FedEx return process, with return postage potentially deducted. Damage claims require documentation, while irritation reports involve review of details such as the lot information. Neither process is a guaranteed refund for every opened bottle. [2]
A prospective buyer should read the policy attached to the actual order once the product is available. We did not test support responsiveness, receive authorization or observe reimbursement. A detailed policy can be summarized accurately while the outcome of an individual claim remains unknown and order-specific.
Wait for an identifiable order before calculating value
A useful future price comparison needs the Original version, the package volume and an available offer captured together. A price from a multi-item promotion would add an assumption about allocation before the comparison even begins. This review leaves that calculation open until the relevant records can support it.
The same discipline applies to the formula: save the actual ingredient declaration rather than only the fruit-water headline. That preserves which percentage belongs to which material and makes a later version change easier to recognize without assuming an unchanged composition.
The unresolved offer is part of the conclusion
The Original serum has an identifiable formula presentation but no verified current purchasable price in the captured record. Reporting that gap is more useful than importing an attractive amount from a bundle. It prevents a cost comparison from appearing more complete than the underlying evidence allows.
The Vinoperfect review raises a different laboratory-versus-clinical question. These entries expand the retail comparison without declaring either serum a substitute for prescribed melasma care. CoreAge Rx’s advertised placement is separately disclosed; it is not evidence that any listed product will outperform another.
Sources & further reading
Provider pages establish what a brand markets. Clinical and regulatory sources establish the limits of the evidence. Each source has its own last-checked date below.
- Vitamin illuminating Serum_Original – EQQUALBERRYOfficial product or purchase record; claims and transaction performance not independently tested · Checked October 14, 2026
- Refund policy – EQQUALBERRYOfficial product or purchase record; claims and transaction performance not independently tested · Checked October 14, 2026
- AAD: melasma diagnosis and treatmentAAD guidance rechecked October 10, 2026. · Checked October 14, 2026
- AAD: melasma self-careAAD guidance rechecked October 10, 2026. · Checked October 14, 2026